A Google Translate screenshot correctly shows that the name of the pharmaceutical company AstraZeneca, when written as “A ...

Positive high-level results from the phase III KALOS and LOGOS trials in patients with uncontrolled asthma showed that AstraZeneca’s fixed-dose triple-combination ...

But the Games Independent Infrastructure and Coordination Authority does have at least one piece of public-facing progress to show for its work – a new corporate logo for the planned Brisbane ...

Thanks to some smart (and aggressive) marketing, Duolingo has cemented itself as one of the most popular language learning apps in the world. That said, it isn't without competition: There are ...

London: British pharmaceutical giant AstraZeneca announced Tuesday that it has begun moving some of its European production to the United States, ahead of President Donald Trump's possible tariffs ...

The history of logos is intrinsically tied to the evolution of branding and visual identity. From ancient civilisations to the digital age, symbols have served as powerful tools for communication and ...

AstraZeneca (AZN) CEO Pascal Soriot is not overly concerned about the threat of tariffs by the Trump administration on pharmaceuticals and said a more favorable corporate tax credit could motivate ...

Revenues came in at $13.59 billion, missing Wall Street's estimates of $13.76 billion. In this photo illustration, the AstraZeneca logo is displayed on a smartphone screen with a stock market chart in ...

AstraZeneca (LON:AZN) shares close higher as revenue misses, earnings beat Despite initially declining, AstraZeneca PLC (ST:AZN) shares closed 0.9% higher after the company’s first-quarter ...

(Alliance News) - AstraZeneca PLC on Monday said growth has continued into 2025, with the chief executive officer saying the pharmaceutical maker has "entered an unprecedented catalyst-rich period ...

AstraZeneca posted increased core earnings per share and sales for the first quarter but warned of mounting legal challenges in China. The British pharmaceutical giant said Tuesday that its core ...